Cardioprotective Effect of Kelor (Moringa oleifera) Leaf Ethanolic Extract against Doxorubicin-Induced Cardiotoxicity in Rats

Fikriansyah Fikriansyah, Mentari Widiastuti, Nindi Wulandari, Prisnu Tirtanirmala, Retno Murwanti

Abstract


The usage of doxorubicin (DOX) as an anticancer drug in cancer patient may cause several side effects. One of that is cardiotoxicity by inducing the expression of nitric oxide synthase which may release nitric oxide (NO) resulting reactive oxygen species (ROS) in the cardiac. DOX needs to be combined with antioxidant since it could supressed ROS in the cardiac and reduce cardiomyopathy. Kelor (Moringa oleifera) is known as the source of antioxidant. This study aim to observe the treatment effects of ethanolic extract of kelor (EEK) on histopathology profile and concentration of NO in rats cardiac. The result from the hematoxylin-eosin staining showed that EEK improved the histopathology profile of rats’ cardiac. Compared with the DOX-only treatment, the structure of cardiac muscle cells treated by ethanolic extract of kelor is more well-arranged and the cells’ nucleus still visible. Concentration of NO was measured by cardiac puncture method. The result showed that the concentration of NO was decrease in line with increasing dose levels of EEK in combination with DOX. But at rats only given with EEK, the concentration of NO is quite high. In conclusion, EEK could be a cochemotherapy agent by reducing the cardiotoxicity effect of DOX.

Keywords : doxorubicin, Moringa oleifera, nitric oxyde, histopathology

 


Full Text:

PDF

References


Arafa H.M., Abd-Ellah M.F., and Hafez H.F., 2005, Abatement by Naringenin of Doxorubicin-Induced Cardiac Toxicity in Rats. J Egpt Cancer Inst., 17 (4), 291-300.

Bustová I. 2009. Risk of Cardiotoxicity of Combination Treatment Radiotherapy and Chemotherapy of Locally Advanced Breast Carcinoma Stage III. Klin Onkol, 22 (1),17-21.

De Beer, EL., Bottone, AE., and Voest EE., 2001, Doxorubicin and Mechanical Performance of Cardiac Trabeculae after Acute and Chronic Treatment: a Review, Eur J Pharmacol, 415, 1-11.

Fogli S., Nieri P., and Breschi M.C., 2004, The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage. FASEB J, 18 (6), 664-75.

Frias M.A., Lang U., Gerber-Wicht C., and James R.W., 2009, Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis, Cardiovasc Res, 85, 118-126.

Garner A.P., Paine M.J., Chinje E.C., Ortize P., Strat Ford I.J., Tew D.G., and Wolf C.R., 1999, Nitric oxide synthases catalyse the activation of redox cycling and bioreductive anticancer agents, Cancer Res, 59, 1929-1934.

Montano, Calderon J.M., Burgos-Moron E., Perez-Guerrero C., and Lopez- Lazaro M., 2011, A Review on Dietary Flavonoid Kaempferol. Mini- Reviews in Medicnal Chemistry, 11, 298-344.

Palmer R.M., Ashton D.S., and Moncada S., 1988, Vascular endothelial cells synthesize nitric oxide from L. arginine, Nat., 333, 664-666.

Schildknecht S., Pape R., Muller N., Robotta M., Marquardt A., Burkle A., Drescher M., and Leist M., 2011, Neuroprotection by minocycline caused by direct and spesific scavenging of peroxynitrite, J Biol Chem., 286 (7), 4991-5002.

Sharma G., Tyagi A.K., Singh R.P., Chan D.C.F., and Agarwal R., 2004, Synergistic Anticancer Effect of Grape Seed Extract and Conventional Cytotoxic Against Human Breast Carcinoma Cells, Breast Cancer Research and Treatment, 85, 1-12.

Siddhuraju P., and Becker K., 2003, Antioxidant Properties of Various Solvent Extracts of Total Phenolic Constituents from Three Different Agroclimatic Origins of Drumstick Tree (Moringa oleifera Lam.) Leaves, J Agric Food Chem, 51 (8), 2144-2155.

Singal P.K., Li T., Kumar D., Danelisen I., and Iliskovic N., 2000, Adriamycin-induced heart failure: mechanism and modulation. Mol Cell Biochem, 207, 77–86.

Tyagi A.K., Agarwal C., Chan D.C.F., and Agarwal R., 2004, Synergistic Anti Cancer Effect of Silibinin with Conventional Cyotoxic Agents Doxorubicin, Cisplatin, and Carboplatin against Human Breast Carcinoma MCF-7 and MDA-MB468 Cells, Oncology Reports,11, 493-499.


Refbacks

  • There are currently no refbacks.